Mesenchymal stem cells and their derived exosomes to combat Covid–19
M Yousefi Dehbidi, N Goodarzi… - Reviews in Medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
[HTML][HTML] Stem cell-based therapy for COVID-19
X Chen, B Liu, C Li, Y Wang, S Geng, X Du… - International …, 2023 - Elsevier
Abstract While The World Health Organization (WHO) has announced that COVID-19 is no
longer a public health emergency of international concern (PHEIC), the risk of reinfection …
longer a public health emergency of international concern (PHEIC), the risk of reinfection …
[HTML][HTML] Development and characterization of phage-display-derived novel human monoclonal antibodies against the receptor binding domain of SARS-CoV-2
JW Kim, SW Min, J Lee, HG Shin, HL Choi, HR Yang… - Biomedicines, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in an ongoing
global pandemic crisis, caused by the life-threatening illness coronavirus disease 2019 …
global pandemic crisis, caused by the life-threatening illness coronavirus disease 2019 …
[HTML][HTML] Specific activation of T cells by an ACE2-based CAR-like receptor upon recognition of SARS-CoV-2 spike protein
P Gonzalez-Garcia, JP Muñoz-Miranda… - International Journal of …, 2023 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of
the Coronavirus Disease 2019 (COVID-19) pandemic, which is still a health issue worldwide …
the Coronavirus Disease 2019 (COVID-19) pandemic, which is still a health issue worldwide …
[HTML][HTML] Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation
S Dubhashi, S Sinha, S Dwivedi, J Ghanekar, S Kadam… - Cureus, 2023 - ncbi.nlm.nih.gov
Methods A randomised, double-blind, placebo-controlled study was conducted to evaluate
the efficacy and safety of Cordyceps capsules (a food supplement) 500 mg as adjuvant …
the efficacy and safety of Cordyceps capsules (a food supplement) 500 mg as adjuvant …
Covid-19 Prevention and Treatment by Targeting Fc-fusion Proteins: An Experience to Fight Emerging Diseases
H Zare, T Farkhondeh, H Bakherad… - Current Molecular …, 2024 - ingentaconnect.com
The coronavirus disease 2019 (Covid-19) pandemic has been considered a major threat to
human health. Effective therapeutic approaches are urgently required. Spike protein and the …
human health. Effective therapeutic approaches are urgently required. Spike protein and the …